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Case report - coronary vasospasm in
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Abstract
Background: Coronary artery spasm (CAS) is an underdiagnosed disease especially in heart transplant patients, and
in those patients the etiology and pathophysiology remain largely unknown, although it has been associated with
cardiac allograft vasculopathy or graft rejection.
Case presentation: We report the case of a heart-transplant patient whose cardiac graft experienced two coronary
vasospasms: the first before transplantation, and the other at one-month of a postoperative course complicated by
primary graft failure.
Conclusion: Our case illustrates that a transplanted heart predisposed with coronary vasospasm may suffer from
early relapse in the recipient despite of complete post-surgical autonomic denervation. Exacerbated endothelial
dysfunction of the donor heart after transplant, with the addition of systemic factors in the recipient may be
involved in the genesis of this puzzling phenomenon.
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Background
Coronary Artery Spasm (CAS) is a condition caused by
the vasoconstriction of the epicardial coronary arteries,
leading to myocardial ischemia that can play a role in
various conditions, from rest angina to acute coronary
syndrome. Several responsible mechanisms have been
reported: abnormal autonomic nervous system, endothe-
lial dysfunction, hyperreactivity of the coronary smooth
muscle and, as recently demonstrated, specific anatomy
of the coronary artery and inflammation of perivascular
component, with a fundamental role played by inflam-
mation of coronary adventitia and perivascular adipose
tissue through Rho-kinase activation, one of the main
molecular mediator in the mechanisms of coronary ar-
tery spasm in animals and humans [1–3].
CAS in heart transplant has previously been described
to be rare [4]. Nevertheless, various degree of asymp-
tomatic vasospasm may be observed during routine cor-
onary angiography in transplanted hearts [5, 6], which
suggests that only the most severe episodes may have
overt clinical consequences, such as symptomatic ven-
tricular arrhythmias, high-degree atrio-ventricular block,
syncope, cardiac arrest, or even myocardial infarction in
case of prolonged ischemia. Denervation of the trans-
planted heart explains the absence of angina in most
cases, although some patients may be symptomatic due
to late graft reinnervation [4, 7–10].
Since autonomic innervation is not necessary to de-
velop CAS in heart transplant [4, 10], pathophysiology
remains poorly understood and hypothetic. Endothelial
damage caused by circulating neurohormonal, immuno-
logical or metabolic factors, is suspected to be the main
trigger by altering vascular smooth muscle response.
Peri-operative ischemia-reperfusion injuries, as well as
preexisting preclinical atherosclerosis in the donor heart
may also promote endothelial dysfunction and be re-
sponsible for abnormal vascular reactivity [8, 11, 12].
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Moreover, CAS has been associated with acute rejection
episodes and cardiac allograft vasculopathy (CAV), a
form of accelerated atherosclerosis characterized by dif-
fuse circumferential neointimal proliferation, which is
recognized as the most important cause of long-term
death in heart transplant patients. Therefore, CAS has
been pointed out as a marker of poor prognosis in heart
transplantation and may actually be the first manifest-
ation of CAV [7, 13].
For the diagnosis, ECG changes in ST-T segments
during chest symptoms, including good response to
nitroderivates, is very important, but the gold standard is
represented by Spasm Provocating Tests (SPT), using ei-
ther Acethylcoline (Ach), either Ergonovine maleate
(EM) or a combination of both (sequential SPT): the cri-
teria of positivity is a > 90% transient stenosis of a coron-
ary artery with signs/symptoms of myocardial ischemia
[14, 15, 16].
Our case illustrates that a transplanted heart predis-
posed with coronary vasospasm may suffer from early
relapse in the recipient despite of complete post-surgical
autonomic denervation.
Case presentation
A 46 years old man with end-stage hypertrophic cardio-
myopathy and electrical storm underwent urgent ortho-
topic heart transplantation: the donor was a 54 years old
woman, known for diabetes, nicotine consumption, mor-
bid obesity, combined ventilation disorder with restric-
tion due to obesity hypoventilation syndrome and
suspected chronic obstructive pulmonary disease, and
history of thrombophilia (activated protein C resistance)
with recurrent deep vein thrombosis and pulmonary em-
bolism in cerebral death due to brain hemorrhage. Pre-
transplant cardiac workup showed a 90% stenosis in the
middle right coronary artery (Fig. 1), with normal LVEF,
and no segmental wall-motion abnormalities or
valvulopathy.
The technically uneventful transplant was completed
with a venous coronary artery bypass graft (CABG) on
the right coronary artery (RCA), with a total ischemic
time of 191 min. After cross-clamp removal and appro-
priate induction therapy with methylprednisolone 500
mg IV, the heart showed severe global biventricular fail-
ure with severe functional mitral regurgitation. In the
absence of preformed donor specific HLA antibodies in
favor of an acute humoral rejection, primary graft failure
was suspected, and mechanical hemodynamic support
was immediately initiated with a central veno-arterial
extracorporeal membrane oxygenation (ECMO) and
intra-aortic balloon pump (IABP), and high dose of
cathecolamines (Noradrenaline up to 30 mcg/min) A
relatively low troponin release was observed during the
first 24 h post-operative (peak at 2386 ng/l), favoring the
hypothesis of myocardial stunning over necrosis.
A cardiac tamponade on post-operative day 1 led to
surgical revision. The intra-operative status was note-
worthy for an occlusion of the venous CABG on the
RCA. A coronary angiogram was urgently performed in
attempt to treat the stenosis in the native vessel. Surpris-
ingly, only a < 50% stenosis could be seen the mid RCA
Fig. 1 Angiography in the donor heart. Arrow indicates critical
stenosis on RCA
Fig. 2 Angiography at day 1: Venous bypass is occluded: broad
arrow indicates the anastomotic stump. Thin arrow indicated the
< 50% stenosis
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(Fig. 2). It was then noticed that the angiogram per-
formed in the donor had not been preceded by the ad-
ministration of nitroglycerine, which retrospectively
spoke for a severe localized vasospasm of the mid RCA
at the site of an atherosclerotic plaque. No further inter-
vention was performed and the ECMO could finally be
weaned on day 9, after full recovery of the LV function
and moderate persistent RV dysfunction.
In stable phase, during his fourth post-transplant week
at the intermediate care unit, the patient developed sus-
tained ventricular tachycardia at rest, with a heart rate of
150 bpm and no associated hemodynamic instability or
even symptoms. Rapid cardioversion was easily achieved
with a single administration of 2 mg magnesium sulfate
IV. Nevertheless, the immediate post-cardioversion 12-
lead ECG and echocardiography respectively showed se-
vere ST-segment elevation in the inferior leads (Fig. 3
and 4) with inferior and inferolateral hypokinesia (Add-
itional files 1, 2 and 3). Urgent cardiac catheterization
showed a severe localized coronary vasospasm in the
proximal RCA (Fig. 5), which was rapidly reversed after
intracoronary injection of 1 mg isosorbide dinitrate. The
ECG and echocardiography quickly normalized after the
acute event, without consecutive elevation of troponins.
An endomyocardial biopsy excluded an acute cellular or
humoral rejection. The patient was treated with
diltiazem without further episodes of arrhythmias or ST-
segment changes during his hospital stay.
Interestingly, a few days before this coronary vaso-
spasm, the patient complained from recurrent abdom-
inal pain followed by melena. A colonoscopy showed
ulcerations in the distal ileum, correlated with reversible
signs of bowel ischemia in two consecutive CT scans,
without evidence of occlusion or embolization in the
mesenteric vessels. We could speculate that systemic
factors in the recipient might favor vasospastic events.
Because of a previously reported case of segmental mes-
enteric ischemia related to mycophenolate mofetil [17],
this drug was replaced by azathioprine without any fur-
ther abdominal pain or bleeding episodes.
Discussion and conclusions
Three lessons can be learned from this case. First, vaso-
spasm should never be forgotten as a possible cause of
angiographic coronary stenosis, even in the setting of
pre-transplant assessment: it may typically develop on
the site of an atherosclerotic plaque, with the risk to
overestimate the severity of a stenosis. In our case, this
led to perform an unnecessary CABG in addition to
transplant, which prolonged the ischemic time of these
54 years-old hearts over 3 h, and participated in the gen-
esis of primary graft failure. The execution of
Fig. 3 ECG: Ventricular tachycardia
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provocation tests during the pre-transplant coronary
angiogram could be considered for the early identifica-
tion of this phenomenon in the donor heart: these tests
have been proven to be not only safe but also useful to
enhance the diagnostic value of a diagnostic angiography
in the population suffering from vasospastic angina [18].
Secondly, it shows that coronary vasospasm may mani-
fest very early in the recipient despite of complete auto-
nomic denervation of the heart, and out of any context
of graft rejection or cardiac graft vasculopathy. Although
this was already reported [8], the particularity of our
case is that a first coronary vasospasm could be docu-
mented in the donor during the pre-transplant coronary
angiogram, which point out that this heart was sensi-
tized to vasospasm in a context of preexistent athero-
sclerosis and probable endothelial dysfunction. Extensive
ischemia-reperfusion injuries induced by the prolonged
and severe primary graft failure and high doses of post-
operative catecholamines may have exacerbated this dys-
function and favored vasospastic response.
Thirdly, our case shows that full heart recovery may
still be possible after 9 days on ECMO support following
primary graft failure with severe biventricular failure,
which is longer compared to previously reported delays,
usually ranging from 72 h to 7 days [19]. This could only
Fig. 4 ECG: ST segment elevation in the inferior leads after cardioversion
Fig. 5 Angiography during right coronary artery vasospasm. Arrow
indicates RCA vasospasm
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be achieved through high-quality multidisciplinary care,
which was life-saving for the patient. Whether CAS was
also involved in primary graft failure in the immediate
post-operative phase will never be known, though it has
been reported elsewhere [14].
In conclusion, coronary vasospasm in heart-transplant
patients is a complex and multi-faceted problem that is
not limited to the context of graft rejection or cardiac
graft vasculopathy. Independently of cardiac autonomic
innervation, endothelial dysfunction - possibly induced
by immunological, neurohormonal and metabolic factors
– is now seen as the main trigger for this phenomenon,
and may be exacerbated by ischemia-reperfusion injury
in the near post-operative course. Our case identifies
pre-existent atherosclerosis and vasospasm in the donor
heart as a clear risk factor for early post-transplant
vasospasm.
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